•
Sep 30, 2020

Chemours Q3 2020 Earnings Report

Chemours' third quarter results demonstrated progress in executing the business plan and steady recovery of key markets. The company maintained a strong balance sheet and liquidity position, while also advancing its Corporate Responsibility Commitment.

Key Takeaways

Chemours reported net sales of $1.2 billion and net income of $76 million for the third quarter of 2020. The company's adjusted EBITDA was $210 million, and it generated a free cash flow of $252 million. The results reflect the company's resilience and execution in a challenging environment.

Net Sales of $1.2 billion.

Net Income of $76 million, with EPS of $0.46.

Adjusted Net Income of $78 million, with Adjusted EPS of $0.47.

Free Cash Flow of $252 million, a $92 million improvement from prior year.

Total Revenue
$1.23B
Previous year: $1.39B
-11.3%
EPS
$0.47
Previous year: $0.59
-20.3%
Gross Profit
$257M
Previous year: $294M
-12.6%
Cash and Equivalents
$956M
Previous year: $694M
+37.8%
Free Cash Flow
$252M
Previous year: $160M
+57.5%
Total Assets
$6.95B
Previous year: $7.46B
-6.8%

Chemours

Chemours

Chemours Revenue by Segment

Forward Guidance

Chemours is confident in creating sustained value through the economic recovery and remains committed to achieving its full potential.

Revenue & Expenses

Visualization of income flow from segment revenue to net income